KLOW80 (PEPTIDES).jpg

KLOW 80mg - COA Certified - Research Grade Peptide

$90.00

🧬 KLOW Peptide Blend — GHK‑Cu + BPC‑157 + TB‑500 + KPV

KLOW is a premium four‑peptide research blend combining GHK‑Cu, BPC‑157, TB‑500, and KPV, engineered for advanced studies involving cellular signaling, inflammation‑response modeling, angiogenesis, structural remodeling, and multi‑pathway peptide synergy. Designed for controlled laboratory environments, KLOW is widely referenced across Canadian research institutions requiring high‑purity, COA‑verified peptide materials with broad mechanistic coverage.

Its multi‑domain composition makes KLOW a preferred choice for researchers exploring complex tissue‑modeling systems, extracellular‑matrix behavior, and interacting peptide pathways.

🔍 What Is KLOW?

KLOW is a research‑grade, multi‑pathway peptide blend combining four widely studied compounds:

  • GHK‑Cu (50 mg) — copper‑binding tripeptide referenced in studies involving gene expression, collagen‑associated pathways, and regenerative signaling

  • BPC‑157 (10 mg) — pentadecapeptide used in research involving connective‑tissue models, angiogenesis‑linked pathways, and cellular‑signaling dynamics

  • TB‑500 (10 mg) — synthetic thymosin beta‑4 fragment associated with actin modulation, cell migration, and structural‑modeling research

  • KPV (10 mg) — Lys‑Pro‑Val tripeptide examined for cytokine‑signaling modulation and inflammation‑response pathways

Together, these peptides form a multi‑mechanism research complex suitable for studies requiring broad pathway coverage, synergistic peptide interactions, and multi‑domain cellular modeling.

📡 Mechanistic Overview

🔷 GHK‑Cu — Regenerative & Gene‑Modulating Peptide

  • Referenced in studies involving gene networks linked to tissue remodeling

  • Examined for collagen‑associated pathways and extracellular‑matrix behavior

  • Used in research involving oxidative‑stress and inflammation‑response signaling

🔶 BPC‑157 — Connective‑Tissue & Structural‑Integrity Peptide

  • Studied in tendon, ligament, and soft‑tissue modeling environments

  • Referenced in angiogenesis‑linked and nitric‑oxide‑associated pathways

  • Utilized in epithelial‑integrity and cellular‑resilience research

🔵 TB‑500 — Actin‑Modulating Peptide Fragment

  • Supports research involving actin‑linked cell migration

  • Referenced in angiogenesis and structural‑remodeling models

  • Used in studies involving muscle, fascia, and extracellular‑matrix dynamics

🟣 KPV — Inflammation‑Modulating Tripeptide

  • Examined for its influence on NF‑κB‑associated cytokine signaling

  • Used in gut, skin, and immune‑related inflammation‑response models

  • Supports research involving epithelial‑barrier environments

🧱 Structural Overview

🧪 Molecular Composition

  • GHK‑Cu: Tripeptide + copper ion

  • BPC‑157: 15‑amino‑acid pentadecapeptide

  • TB‑500: Actin‑binding peptide fragment

  • KPV: Lys‑Pro‑Val tripeptide

🧬 Functional Domains

  • Regenerative domain: GHK‑Cu + TB‑500

  • Inflammation‑modulating domain: KPV

  • Connective‑tissue domain: BPC‑157

  • Synergy domain: Multi‑pathway structural and cellular modeling

🎯 Pathway Targets

  • Angiogenesis (VEGF‑associated signaling)

  • Actin‑modulated cell migration

  • Cytokine‑signaling pathways (NF‑κB, TNF‑α)

  • Collagen‑linked tissue remodeling

  • Fibroblast‑activity and extracellular‑matrix organization

🔬 Research Focus Areas

KLOW is referenced in research involving:

  • Soft‑tissue and structural‑remodeling models

  • Inflammation‑aware repair environments

  • Multi‑peptide synergy and pathway‑interaction studies

  • Angiogenesis and cellular‑migration dynamics

  • Comparative research vs. single‑peptide controls

  • Extracellular‑matrix and fibroblast‑behavior modeling

Its multi‑domain composition makes it suitable for complex, multi‑pathway cellular investigations across Canadian research settings.

🇨🇦 Optimized for Canadian Research Environments

BlueNexLabs supplies KLOW to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and Canada‑wide, offering:

  • High‑purity, COA‑verified peptide materials

  • Consistent batch quality and traceability

  • Audit‑safe RUO labeling

  • Fast, Canada‑wide fulfillment

  • Research‑focused support for multi‑pathway peptide studies

This ensures Canadian researchers have reliable access to premium multi‑peptide blends for advanced cellular‑mechanism modeling.

📄 Documentation & COA Visibility

Each batch includes:

  • MS identity confirmation

  • HPLC purity profile

  • Solvent system details

  • RUO‑only designation

All documentation is structured for audit‑safe compliance and laboratory reproducibility.

❄️ Storage & Handling

  • Store lyophilized blend at –20°C, protected from light and humidity

  • Reconstituted solutions should be kept at 2–8°C

  • Avoid repeated freeze–thaw cycles

  • Use sterile technique for preparation and handling

⚠️ Compliance Notice

KLOW is supplied for laboratory research only. Not for human or veterinary use. No therapeutic, cosmetic, or performance‑related claims are made or implied.

🧬 KLOW Peptide Blend — GHK‑Cu + BPC‑157 + TB‑500 + KPV

KLOW is a premium four‑peptide research blend combining GHK‑Cu, BPC‑157, TB‑500, and KPV, engineered for advanced studies involving cellular signaling, inflammation‑response modeling, angiogenesis, structural remodeling, and multi‑pathway peptide synergy. Designed for controlled laboratory environments, KLOW is widely referenced across Canadian research institutions requiring high‑purity, COA‑verified peptide materials with broad mechanistic coverage.

Its multi‑domain composition makes KLOW a preferred choice for researchers exploring complex tissue‑modeling systems, extracellular‑matrix behavior, and interacting peptide pathways.

🔍 What Is KLOW?

KLOW is a research‑grade, multi‑pathway peptide blend combining four widely studied compounds:

  • GHK‑Cu (50 mg) — copper‑binding tripeptide referenced in studies involving gene expression, collagen‑associated pathways, and regenerative signaling

  • BPC‑157 (10 mg) — pentadecapeptide used in research involving connective‑tissue models, angiogenesis‑linked pathways, and cellular‑signaling dynamics

  • TB‑500 (10 mg) — synthetic thymosin beta‑4 fragment associated with actin modulation, cell migration, and structural‑modeling research

  • KPV (10 mg) — Lys‑Pro‑Val tripeptide examined for cytokine‑signaling modulation and inflammation‑response pathways

Together, these peptides form a multi‑mechanism research complex suitable for studies requiring broad pathway coverage, synergistic peptide interactions, and multi‑domain cellular modeling.

📡 Mechanistic Overview

🔷 GHK‑Cu — Regenerative & Gene‑Modulating Peptide

  • Referenced in studies involving gene networks linked to tissue remodeling

  • Examined for collagen‑associated pathways and extracellular‑matrix behavior

  • Used in research involving oxidative‑stress and inflammation‑response signaling

🔶 BPC‑157 — Connective‑Tissue & Structural‑Integrity Peptide

  • Studied in tendon, ligament, and soft‑tissue modeling environments

  • Referenced in angiogenesis‑linked and nitric‑oxide‑associated pathways

  • Utilized in epithelial‑integrity and cellular‑resilience research

🔵 TB‑500 — Actin‑Modulating Peptide Fragment

  • Supports research involving actin‑linked cell migration

  • Referenced in angiogenesis and structural‑remodeling models

  • Used in studies involving muscle, fascia, and extracellular‑matrix dynamics

🟣 KPV — Inflammation‑Modulating Tripeptide

  • Examined for its influence on NF‑κB‑associated cytokine signaling

  • Used in gut, skin, and immune‑related inflammation‑response models

  • Supports research involving epithelial‑barrier environments

🧱 Structural Overview

🧪 Molecular Composition

  • GHK‑Cu: Tripeptide + copper ion

  • BPC‑157: 15‑amino‑acid pentadecapeptide

  • TB‑500: Actin‑binding peptide fragment

  • KPV: Lys‑Pro‑Val tripeptide

🧬 Functional Domains

  • Regenerative domain: GHK‑Cu + TB‑500

  • Inflammation‑modulating domain: KPV

  • Connective‑tissue domain: BPC‑157

  • Synergy domain: Multi‑pathway structural and cellular modeling

🎯 Pathway Targets

  • Angiogenesis (VEGF‑associated signaling)

  • Actin‑modulated cell migration

  • Cytokine‑signaling pathways (NF‑κB, TNF‑α)

  • Collagen‑linked tissue remodeling

  • Fibroblast‑activity and extracellular‑matrix organization

🔬 Research Focus Areas

KLOW is referenced in research involving:

  • Soft‑tissue and structural‑remodeling models

  • Inflammation‑aware repair environments

  • Multi‑peptide synergy and pathway‑interaction studies

  • Angiogenesis and cellular‑migration dynamics

  • Comparative research vs. single‑peptide controls

  • Extracellular‑matrix and fibroblast‑behavior modeling

Its multi‑domain composition makes it suitable for complex, multi‑pathway cellular investigations across Canadian research settings.

🇨🇦 Optimized for Canadian Research Environments

BlueNexLabs supplies KLOW to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and Canada‑wide, offering:

  • High‑purity, COA‑verified peptide materials

  • Consistent batch quality and traceability

  • Audit‑safe RUO labeling

  • Fast, Canada‑wide fulfillment

  • Research‑focused support for multi‑pathway peptide studies

This ensures Canadian researchers have reliable access to premium multi‑peptide blends for advanced cellular‑mechanism modeling.

📄 Documentation & COA Visibility

Each batch includes:

  • MS identity confirmation

  • HPLC purity profile

  • Solvent system details

  • RUO‑only designation

All documentation is structured for audit‑safe compliance and laboratory reproducibility.

❄️ Storage & Handling

  • Store lyophilized blend at –20°C, protected from light and humidity

  • Reconstituted solutions should be kept at 2–8°C

  • Avoid repeated freeze–thaw cycles

  • Use sterile technique for preparation and handling

⚠️ Compliance Notice

KLOW is supplied for laboratory research only. Not for human or veterinary use. No therapeutic, cosmetic, or performance‑related claims are made or implied.